{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:45:40Z","timestamp":1785717940377,"version":"3.56.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005216","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T00:00:00Z","timestamp":1295395200000}}],"reference-count":123,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005216.pub2","type":"journal-article","created":{"date-parts":[[2011,1,6]],"date-time":"2011-01-06T00:46:23Z","timestamp":1294274783000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Medical methods for mid-trimester termination of pregnancy"],"prefix":"10.1002","volume":"2011","author":[{"given":"Hajo","family":"Wildschut","sequence":"first","affiliation":[{"name":"Erasmus Medical Center; Department of Obstetrics and Gynaecology; PO Box 2040 Rotterdam Netherlands 3000 CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke I","family":"Both","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center; Department of Obstetrics and Gynaecology; PO Box 2040 Rotterdam Netherlands 3000 CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Medema","sequence":"additional","affiliation":[{"name":"Bouman GGZ; Pieter de Hoogh Weg 14 Rotterdam Netherlands 3024 BH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeke","family":"Thomee","sequence":"additional","affiliation":[{"name":"The Royal Marsden Hospital; Fulham Road London UK SW 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F","family":"Wildhagen","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center; Department of Urology and Obstetrics and Gynecology; PO Box 2040 Rotterdam Netherlands 3000 CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Kapp","sequence":"additional","affiliation":[{"name":"World Health Organization; Department of Reproductive Health and Research; 20 Rue Appia Geneva 27 Switzerland CH-1211"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,19]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD005216.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ajog.2003.09.037","article-title":"Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation","volume":"190","author":"Akoury","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD005216.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1479-828X.1996.tb02714.x","article-title":"A randomized trial of 2 regimens for the administration of vaginal prostaglandins (gemeprost) for the induction of midtrimester abortion","volume":"36","author":"Armatage","year":"1996","journal-title":"The Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"issue":"11","key":"10.1002\/14651858.CD005216.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1046\/j.1471-0528.2002.01462.x","article-title":"A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy","volume":"109","author":"Bartley","year":"2002","journal-title":"BJOG"},{"issue":"4","key":"10.1002\/14651858.CD005216.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1067\/mob.2002.127461","article-title":"A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination","volume":"187","author":"Bebbington","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"21","key":"10.1002\/14651858.CD005216.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.3923\/pjbs.2008.2505.2508","article-title":"Vaginal versus oral misoprostol for second trimester pregnancy termination: a randomised trial","volume":"11","author":"Behrashi","year":"2008","journal-title":"Pakistan Journal of Biological Sciences"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1479-828X.2008.00831.x","article-title":"A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks","volume":"48","author":"Bhattacharjee","year":"2008","journal-title":"The Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"issue":"5","key":"10.1002\/14651858.CD005216.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0029-7844(95)00011-F","article-title":"Second-trimester abortion by intramuscular 15-methyl-prostaglandin F2 alpha or intravaginal prostaglandin E2 suppositories: a randomized trial","volume":"85","author":"Borgida","year":"1995","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD005216.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/humrep\/den425","article-title":"A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion","volume":"24","author":"Chai","year":"2009","journal-title":"Human Reproduction"},{"issue":"10","key":"10.1002\/14651858.CD005216.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/oxfordjournals.humrep.a137927","article-title":"The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486)","volume":"8","author":"El-Refaey","year":"1993","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD005216.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/oxfordjournals.humrep.a135965","article-title":"Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens","volume":"10","author":"El-Refaey","year":"1995","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0011|cit11","first-page":"177","article-title":"Intra-amniotic injection of oxytetracycline hydrochloride for termination of mid trimester abortion","volume":"26","author":"Faktor","year":"1988","journal-title":"Gynecologic and Obstetric Investvestigation"},{"issue":"8","key":"10.1002\/14651858.CD005216.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/humrep\/dei037","article-title":"A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation","volume":"20","author":"Hamoda","year":"2005","journal-title":"Human Reproduction"},{"issue":"9","key":"10.1002\/14651858.CD005216.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1471-0528.2005.00727.x","article-title":"A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination","volume":"112","author":"Herabutya","year":"2005","journal-title":"BJOG"},{"issue":"5","key":"10.1002\/14651858.CD005216.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0010-7824(96)00061-3","article-title":"Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial","volume":"53","author":"Ho","year":"1996","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD005216.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0029-7844(97)00419-5","article-title":"Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy","volume":"90","author":"Ho","year":"1997","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3109\/00016349709024610","article-title":"Comparison of ethacridine lactate and prostaglandin E2 in second trimester medical abortion","volume":"76","author":"Inan","year":"1996","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD005216.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/01.AOG.0000289577.32274.a5","article-title":"Mifepristone in second-trimester medical abortion: A randomized controlled trial","volume":"110","author":"Kapp","year":"2007","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/00016340500345337","article-title":"Randomized study on the effect of adding oxytocin to ethacridine lactate or misoprostol for second-trimester termination of pregnancy","volume":"85","author":"Kelekci","year":"2006","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD005216.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/0144361031000120923","article-title":"Second-trimester pregnancy termination: comparison of three different methods","volume":"23","author":"Makhlouf","year":"2003","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD005216.pub2-BIB0020|cit20","first-page":"165","article-title":"Termination of second trimester pregnancies: a blind study using hypertonic saline and prostaglandins F2a - a preliminary report","volume":"25","author":"Mehta","year":"1975","journal-title":"Journal of Obstetrics and Gynaecology India"},{"issue":"2","key":"10.1002\/14651858.CD005216.pub2-BIB0021|cit21","first-page":"165","article-title":"Termination of second trimester pregnancies: a blind study using hypertonic saline and prostaglandins F2a - a preliminary report","volume":"25","author":"Mehta","year":"1975","journal-title":"Journal of Obstetrics and Gynaecology India"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0028-2243(79)90132-1","article-title":"Use of prostaglandin, hypertonic saline and oxytocin for second-trimester abortion","volume":"9\/6","author":"Muzsnai","year":"1979","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0028-2243(79)90132-1","article-title":"Use of prostaglandin, hypertonic saline and oxytocin for second-trimester abortion","volume":"9\/6","author":"Muzsnai","year":"1979","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0028-2243(79)90132-1","article-title":"Use of prostaglandin, hypertonic saline and oxytocin for second-trimester abortion","volume":"9\/6","author":"Muzsnai","year":"1979","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0028-2243(79)90132-1","article-title":"Use of prostaglandin, hypertonic saline and oxytocin for second-trimester abortion","volume":"9\/6","author":"Muzsnai","year":"1979","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"10","key":"10.1002\/14651858.CD005216.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/humrep\/15.10.2205","article-title":"Randomized comparison of vaginal (200 \u00b5g every 3 hrs) and oral (400 \u00b5g every 3 hrs) misoprostol when combined with mifepristone in termination of second trimester pregnancy","volume":"15","author":"Ngai","year":"2000","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0027|cit27","first-page":"57","article-title":"Prostaglandin F2alpha and oxytocin compared with hypertonic saline and oxytocin for the induction of second trimester abortion.","volume":"37","author":"Nielsen","year":"1975","journal-title":"Acta Obstetricia et Gynecologica Scandinavica. Supplement"},{"issue":"6","key":"10.1002\/14651858.CD005216.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0029-7844(97)00491-2","article-title":"A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion","volume":"90","author":"Nuutila","year":"1997","journal-title":"Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD005216.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0029-7844(97)00491-2","article-title":"A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion","volume":"90","author":"Nuutila","year":"1997","journal-title":"Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD005216.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0029-7844(97)00491-2","article-title":"A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion","volume":"90","author":"Nuutila","year":"1997","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/00016347809154027","article-title":"Comparison of extra-amniotic instillation of rivanol and PGF2a either separately or in combination followed by oxytocin for second trimester abortion","volume":"57","author":"Olund","year":"1978","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD005216.pub2-BIB0032|cit32","first-page":"245","article-title":"A comparison of low-dose and high-dose protocols of vaginal misoprostol for second trimester termination of pregnancy","volume":"36","author":"Ozerkan","year":"2009","journal-title":"Clinical and Experimental Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD005216.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1447-0756.2008.00757.x","article-title":"Randomized comparison of dry tablet insertion versus gel form of vaginal misoprostol for second trimester pregnancy termination","volume":"34","author":"Pongsatha","year":"2008","journal-title":"The Journal of Obstetrics and Gynaecology Research"},{"issue":"2","key":"10.1002\/14651858.CD005216.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0010-7824(84)90027-1","article-title":"Randomized trial of intracervical prostaglandin E2 gel and intra-amniotic prostaglandin F2alfa for induction of second trimester abortion","volume":"29","author":"Sorensen","year":"1984","journal-title":"Contraception"},{"issue":"10","key":"10.1002\/14651858.CD005216.pub2-BIB0035|cit35","first-page":"737","article-title":"Mid-trimester termination of pregnancy--a randomised controlled trial of two prostaglandin regimens","volume":"83","author":"Steyn","year":"1993","journal-title":"South African Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD005216.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.ajog.2005.02.082","article-title":"A prospective, randomized comparison of vaginal misoprostol versus intra-amniotic prostaglandins for midtrimester termination of pregnancy","volume":"193","author":"Su","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1471-0528.2004.00222.x","article-title":"A prospective randomized comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy","volume":"111","author":"Tang","year":"2004","journal-title":"BJOG"},{"issue":"11","key":"10.1002\/14651858.CD005216.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/humrep\/dei196","article-title":"A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation","volume":"20","author":"Tang","year":"2005","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD005216.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0010-7824(96)00132-1","article-title":"A randomised study of two doses or gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy","volume":"54","author":"Thong","year":"1996","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD005216.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/humrep\/den328","article-title":"Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomised controlled equivalence trial","volume":"24","author":"Hertzen","year":"2009","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1071\/RD9900495","article-title":"Second-trimester termination with 16,16 dimethyl-PGE1-methyl ester (gemeprost) compared with a regimen that included intra-amniotic PGF2a and hypertonic saline","volume":"2","author":"Waldron","year":"1990","journal-title":"Reproduction, Fertility, and Development"},{"issue":"7","key":"10.1002\/14651858.CD005216.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1471-0528.1996.tb09842.x","article-title":"A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol","volume":"103","author":"Webster","year":"1996","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/bmj.1.6022.1373","article-title":"Comparison of intra-amniotic prostaglandin F2alpha and hypertonic saline for induction of second-trimester abortion","volume":"1","author":"No authors","year":"1976","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD005216.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0010-7824(98)00099-7","article-title":"Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial","volume":"58","author":"Wong","year":"1998","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD005216.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humrep\/15.3.709","article-title":"A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial","volume":"15","author":"Wong","year":"2000","journal-title":"Human Reproduction"},{"issue":"3(2)","key":"10.1002\/14651858.CD005216.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1479-828X.1989.tb01747.x","article-title":"Mid-trimester abortion by extra-amniotic emcredil versus normal saline","volume":"29","author":"Zauva","year":"1989","journal-title":"The Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"issue":"9","key":"10.1002\/14651858.CD005216.pub2-BIB0047|cit47","first-page":"237","article-title":"Comparative study of midtrimester termination of pregnancy using hypertonic saline, ethacridine lactate, prostaglandin analogue and iodine-saline","volume":"90","author":"Allahbadia","year":"1992","journal-title":"Journal of the Indian Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD005216.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0010-7824(81)90088-3","article-title":"The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion","volume":"24","author":"Ballard","year":"1981","journal-title":"Contraception"},{"issue":"8","key":"10.1002\/14651858.CD005216.pub2-BIB0049|cit49","first-page":"511","article-title":"Mifepristone followed by high-dose oxytocin drip for second-trimester abortion","volume":"54","author":"Ben-Meir","year":"2009","journal-title":"The Journal of Reproductive Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005216.pub2-BIB0050|cit50","first-page":"173","article-title":"Randomized comparison of 3 misoprostol protocols for abortion induction at 13-20 weeks of gestation","volume":"50","author":"Caliskan","year":"2005","journal-title":"The Journal of Reproductive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005216.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/13625180802360865","article-title":"Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial","volume":"14","author":"Caliskan","year":"2009","journal-title":"The European Journal of Contraception & Reproductive Health Care"},{"issue":"1","key":"10.1002\/14651858.CD005216.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.contraception.2007.09.007","article-title":"Second-trimester pregnancy termination with 600-\u03bcg vs. 400-\u03bcg vaginal misoprostol and systematic curettage post expulsion: a randomized trial","volume":"77","author":"Carbonell","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD005216.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1520-6661(199805\/06)7:3<115::AID-MFM3>3.0.CO;2-N","article-title":"Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial","volume":"7","author":"Dickinson","year":"1998","journal-title":"The Journal of Maternal-Fetal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005216.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1067\/mob.2002.121085","article-title":"The optimization of intravaginal misoprostol dosing schedules in second trimester pregnancy termination","volume":"186","author":"Dickinson","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD005216.pub2-BIB0055|cit55","first-page":"1294","article-title":"A comparison of oral misoprostol with vaginal misoprostol administration in second-trimester pregnancy termination for fetal abnormality","volume":"101","author":"Dickinson","year":"2003","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD005216.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1067\/S0002-9378(03)00659-8","article-title":"A randomized comparison of two regimens of misoprostol for second-trimester pregnancy termination","volume":"189","author":"Feldman","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD005216.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/oxfordjournals.humrep.a136786","article-title":"Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses","volume":"3","author":"Frydman","year":"1988","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD005216.pub2-BIB0058|cit58","first-page":"429","article-title":"Second-trimester termination of pregnancy by extra-amniotic prostaglandin F2alpha or endocervical misoprostol. A comparative study","volume":"77","author":"Ghorab","year":"1998","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/j.1879-3479.1980.tb00302.x","article-title":"The relative value of two concentrations of hypertonic saline for midtrimester abortion","volume":"17","author":"Ghodh","year":"1980","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"4","key":"10.1002\/14651858.CD005216.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1479-828X.2001.tb01318.x","article-title":"A randomised trial of oral versus vaginal administration of misoprostol for the purpose of mid-trimester termination of pregnancy","volume":"41","author":"Gilbert","year":"2001","journal-title":"The Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"issue":"1-2","key":"10.1002\/14651858.CD005216.pub2-BIB0061|cit61","first-page":"7","article-title":"Midtrimester abortion by ethacridine lactate","volume":"79","author":"Goswami","year":"1982","journal-title":"Journal of the Indian Medical Association"},{"issue":"6","key":"10.1002\/14651858.CD005216.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1159\/000088048","article-title":"Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination","volume":"20","author":"Guix","year":"2005","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD005216.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1447-0756.2001.tb01235.x","article-title":"Second trimester pregnancy termination: a comparison of 600 and 800 micrograms of intravaginal misoprostol","volume":"27","author":"Herabutya","year":"2001","journal-title":"The Journal of Obstetrics and Gynaecology Research"},{"issue":"5","key":"10.1002\/14651858.CD005216.pub2-BIB0064|cit64","first-page":"439","article-title":"Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea. A prospective randomized trial","volume":"30","author":"Hidar","year":"2001","journal-title":"Journal de Gynecologie, Obstetrique et Biologie de la Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD005216.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0020-7292(91)90668-U","article-title":"Mid-trimester termination of pregnancy with 16,16-dimethyl-trans-delta 2 PGE1 vaginal pessaries: a comparison with intra- and extra-amniotic prostaglandin E2 administration","volume":"35","author":"Hill","year":"1991","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0010-7824(93)90085-L","article-title":"Termination of second trimester pregnancy with sulprostone and mifepristone: a randomized double-blind placebo-controlled trial","volume":"47","author":"Ho","year":"1993","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD005216.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJM199408043310502","article-title":"A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy","volume":"331","author":"Jain","year":"1994","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD005216.pub2-BIB0068|cit68","first-page":"571","article-title":"A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination","volume":"93","author":"Jain","year":"1999","journal-title":"Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD005216.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/14767050802283027","article-title":"Mifepristone and misoprostol versus dilapan and sulprostone for second trimester termination of pregnancy","volume":"21","author":"Jansen","year":"2008","journal-title":"The Journal of Maternal-Fetal & Neonatal Medicine"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000010151","article-title":"Comparative study of cervical laminar tents prior to extra-amniotic injection of ethacridine lactate (rivanol) and a condom-nelathon catheter method for second-trimester pregnancy interruption in Vietnam","volume":"48","author":"J\u00e4rnbert","year":"1999","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"6","key":"10.1002\/14651858.CD005216.pub2-BIB0071|cit71","first-page":"293","article-title":"Gemeprost, sulprostone and dinoprostone for induced abortion in the 15th-24th week of pregnancy","volume":"120","author":"Kamali","year":"1998","journal-title":"Zentralblatt fur Gynakologie"},{"issue":"6","key":"10.1002\/14651858.CD005216.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.contraception.2007.08.004","article-title":"A randomized comparison of misoprostol to intrauterine instillation of hypertonic saline plus a prostaglandin F2\u03b1 analogue for second-trimester induction termination in Uzbekistan","volume":"76","author":"Kapp","year":"2007","journal-title":"Contraception"},{"issue":"4","key":"10.1002\/14651858.CD005216.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/00016348309156226","article-title":"Second-trimester abortion by extra-amniotic instillation of Rivanol combined with intravenous administration of oxytocin or prostaglandin F2 alpha","volume":"62","author":"Klinte","year":"1983","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD005216.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/humrep\/17.6.1483","article-title":"Inhibition of progesterone secretion with trilostane for midtrimester termination of pregnancy: randomized controlled trials","volume":"17","author":"Roux","year":"2002","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD005216.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0010-7824(81)80004-2","article-title":"Abortion during mid-pregnancy by rivanol-catheter supplemented with PGF2a drip-infusion or quinine hydrochloride","volume":"23","author":"Manabe","year":"1981","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD005216.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/004947550103100315","article-title":"The use of misoprostol for mid-trimester therapeutic termination of pregnancy","volume":"31","author":"Munthali","year":"2001","journal-title":"Tropical Doctor"},{"issue":"3","key":"10.1002\/14651858.CD005216.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijgo.2005.11.010","article-title":"Vaginal vs. oral misoprostol for mid-trimester abortion","volume":"92","author":"Nigam","year":"2006","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD005216.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijgo.2005.02.018","article-title":"Second trimester abortion using intravaginal misoprostol [brief communication]","volume":"89","author":"Niromanesh","year":"2005","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"6","key":"10.1002\/14651858.CD005216.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/01443610600811383","article-title":"Misoprostol (alone) in second trimester terminations of pregnancy: as effective as gemeprost?","volume":"26","author":"Nor Azlin","year":"2006","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD005216.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ajog.2005.05.087","article-title":"High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial","volume":"193","author":"Nuthalapaty","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD005216.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/00016347909154928","article-title":"The effect of indomethacin on the instillation-abortion interval in rivanol-induced mid-trimester abortion","volume":"58","author":"Olund","year":"1979","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD005216.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0029-7844(96)00132-9","article-title":"Concentrated oxytocin plus low-dose prostaglandin E2 compared with prostaglandin E2 vaginal suppositories for second-trimester pregnancy termination","volume":"88","author":"Owen","year":"1996","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD005216.pub2-BIB0083|cit83","first-page":"48","article-title":"Vaginal misoprostol vs. concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination","volume":"8","author":"Owen","year":"1999","journal-title":"J Matern Fetal Med"},{"issue":"5","key":"10.1002\/14651858.CD005216.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0002-9378(99)70081-5","article-title":"Second-trimester uterine evacuation: A comparison of intra-amniotic (15S)-15-methyl-prostaglandin F2alpha and intravaginal misoprostol","volume":"181","author":"Perry","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD005216.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/j.1879-3479.1980.tb00238.x","article-title":"Abortion with sulprostone, a prostaglandin E2 derivative","volume":"18","author":"Pulkkinen","year":"1980","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/j.1879-3479.1976.tb00072.x","article-title":"Midtrimester abortion: a comparison of intra-amniotic Prostaglandin F2a and hypertonic saline","volume":"14","author":"Ragab","year":"1976","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD005216.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.AOG.0000128947.31887.94","article-title":"Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second trimester labor induction","volume":"104","author":"Ramsey","year":"2004","journal-title":"Obstetrics and Gynecology"},{"issue":"12","key":"10.1002\/14651858.CD005216.pub2-BIB0088|cit88","first-page":"432","article-title":"Mid-trimester pregnancy termination with ethacridine lactate","volume":"82","author":"Shukla","year":"1984","journal-title":"Journal of the Indian Medical Association"},{"issue":"3","key":"10.1002\/14651858.CD005216.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0028-2243(86)90031-6","article-title":"Midtrimester abortion by intracervical prostaglandin E2","volume":"21","author":"Stampe S\u00f8rensen","year":"1986","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"8","key":"10.1002\/14651858.CD005216.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1471-0528.1993.tb14269.x","article-title":"Induction of second trimester abortion with mifepristone and gemeprost","volume":"100","author":"Thong","year":"1993","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0010-7824(92)90127-F","article-title":"A study of gemeprost alone, dilapan of mifepristone in combination with gemeprost for the termination of second trimester pregnancy","volume":"46","author":"Thong","year":"1992","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD005216.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0010-7824(96)00115-1","article-title":"Termination of second trimester pregnancy with gemeprost and misoprostol: a randomized double-blind placebo-controlled trial","volume":"54","author":"Wong","year":"1996","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0301-2115(95)02548-0","article-title":"Second trimester pregnancy termination including fetal death:comparison of five different methods","volume":"69","author":"Yapar","year":"1996","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"5","key":"10.1002\/14651858.CD005216.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00404-007-0374-9","article-title":"Randomized comparison of second trimester pregnancy termination utilizing saline moistened or dry misoprostol","volume":"276","author":"Yilmaz","year":"2007","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"5","key":"10.1002\/14651858.CD005216.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/pd.1710","article-title":"Correlation between prenatal ultrasound and fetal autopsy findings in fetal anomalies terminated in the second trimester","volume":"27","author":"Akgun","year":"2007","journal-title":"Prenatal Diagnosis"},{"issue":"11","key":"10.1002\/14651858.CD005216.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2105\/AJPH.89.11.1649","article-title":"Prenatal diagnosis and selective abortion: a challenge to practice and policy","volume":"89","author":"Asch","year":"1999","journal-title":"American Journal of Public Health"},{"issue":"8","key":"10.1002\/14651858.CD005216.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/15265160902984996","article-title":"Prenatal diagnosis and abortion for congenital abnormalities: is it ethical to provide one without the other?","volume":"9","author":"Ballantyne","year":"2009","journal-title":"The American Journal of Bioethics"},{"issue":"4","key":"10.1002\/14651858.CD005216.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0039-128X(81)90039-8","article-title":"Regio and stereospecific synthesis of 11beta-substituted 19-norsteroids","volume":"37","author":"B\u00e9langer","year":"1981","journal-title":"Steroids"},{"issue":"9","key":"10.1002\/14651858.CD005216.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1471-0528.2009.02190.x","article-title":"Misoprostol for second trimester pregnancy termination in women with prior caesarean: a systematic review","volume":"116","author":"Berghella","year":"2009","journal-title":"BJOG"},{"issue":"6","key":"10.1002\/14651858.CD005216.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1471-0528.2008.01700.x","article-title":"Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome","volume":"115","author":"Boyd","year":"2008","journal-title":"BJOG"},{"issue":"1","key":"10.1002\/14651858.CD005216.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0010-7824(85)90115-5","article-title":"Progesterone receptor blockage. Effect on uterinecontractility and early pregnancy","volume":"32","author":"Bygdeman","year":"1985","journal-title":"Contraception"},{"issue":"31","key":"10.1002\/14651858.CD005216.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0968-8080(08)31385-8","article-title":"An historical overview of second trimester abortion methods","volume":"16 Suppl","author":"Bygdeman","year":"2008","journal-title":"Reproductive Health Matters"},{"issue":"13","key":"10.1002\/14651858.CD005216.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJM200003303421307","article-title":"Medical termination of pregnancy","volume":"342","author":"Christin-Maitre","year":"2000","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005216.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.AOG.0000189095.32382.d0","article-title":"Risk factors associated with presenting for abortion in the second trimester","volume":"107","author":"Drey","year":"2006","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD005216.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM200101043440113","article-title":"Manufacturer's warning regarding unapproved uses of misoprostol","volume":"344","author":"Friedman","year":"2001","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005216.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1056\/NEJM200101043440107","article-title":"Misoprostol and pregnancy","volume":"344","author":"Goldberg","year":"2001","journal-title":"The New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD005216.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jama.280.8.747","article-title":"The continuing need for late abortions","volume":"280","author":"Grimes","year":"1998","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0109|cit109","first-page":"178","article-title":"Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks","volume":"99 Suppl 2","author":"The continuing need for late","year":"2007","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD005216.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejogrb.2010.04.004","article-title":"Mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate for the termination of second trimester pregnancy: a prospective, open-label, randomized\u00a0clinical trial","volume":"151","author":"Hou","year":"2010","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0968-8080(08)31375-5","article-title":"Reasons for second trimester abortions in England and Wales","volume":"1631 Suppl","author":"Ingham","year":"2008","journal-title":"Reproductive Health Matters"},{"issue":"4","key":"10.1002\/14651858.CD005216.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1469-0705.1998.11040246.x","article-title":"Comparison of prenatal ultrasound and postmortem findings in fetuses and infants with central nervous system anomalies","volume":"11","author":"Isaksen","year":"1998","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD005216.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1469-0705.1999.13020117.x","article-title":"Comparison of prenatal ultrasound and postmortem findings in fetuses and infants with congenital heart defects","volume":"13","author":"Isaksen","year":"1999","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"7","key":"10.1002\/14651858.CD005216.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/uog.3871","article-title":"Correlation between prenatal ultrasound and autopsy findings: A study of second-trimester abortions","volume":"28","author":"Kaasen","year":"2006","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD005216.pub2-BIB0115|cit115","first-page":"CD006714","article-title":"Surgical versus medical methods for second trimester induced abortion","volume":"23","author":"Lohr","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD005216.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1471-0528.1992.tb13830.x","article-title":"Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost","volume":"99","author":"Norman","year":"1992","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"7","key":"10.1002\/14651858.CD005216.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/oxfordjournals.humrep.a136809","article-title":"The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium","volume":"3","author":"Swahn","year":"1988","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/17.2.332","article-title":"Pharmacokinetics of different routes of administration of misoprostol","volume":"17","author":"Tang","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005216.pub2-BIB0119|cit119","first-page":"S160","article-title":"Misoprostol: pharmacokinetic profiles,effects on the uterus and side-effects","volume":"99 Suppl 2","author":"Tang","year":"2007","journal-title":"Int J Gynaecol Obstet."},{"issue":"4","key":"10.1002\/14651858.CD005216.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/00016349209021052","article-title":"Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women","volume":"71","author":"Ulmann","year":"1992","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD005216.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1471-0528.2004.00445.x","article-title":"Off-label use of misoprostol in obstetrics: a cautionary tale","volume":"112","author":"Wagner","year":"2005","journal-title":"BJOG"},{"issue":"3","key":"10.1002\/14651858.CD005216.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1471-0528.2004.00490.x","article-title":"Misoprostol and the debate over off-label drug use","volume":"112","author":"Weeks","year":"2005","journal-title":"BJOG"},{"issue":"1","key":"10.1002\/14651858.CD005216.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0029-7844(97)00111-7","article-title":"Absorption kinetics of misoprostol with oral or vaginal administration","volume":"90","author":"Zieman","year":"1997","journal-title":"Obstetrics and Gynecology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005216.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:10:30Z","timestamp":1785715830000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005216.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Fertility Regulation Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,1,19]]},"references-count":123,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005216.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,19]]}}}